{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:21:11Z","timestamp":1782008471299,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11596-024-2934-7","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T06:03:13Z","timestamp":1729749793000},"page":"1036-1046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Key Genes Involved in the Beneficial Mechanism of Hyperbaric Oxygen for Glioblastoma and Predictive Indicators of Hyperbaric Oxygen Prolonging Survival in Glioblastoma Patients"],"prefix":"10.1007","volume":"44","author":[{"given":"Zi-qi","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"issue":"8","key":"2934_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol, 2021,23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"issue":"8","key":"2934_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1177\/0271678X19859847","volume":"39","author":"D Dubinski","year":"2019","unstructured":"Dubinski D, Hattingen E, Senft C, et al. Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies. J Cereb Blood Flow Metab, 2019,39(8):1460\u20131468","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"2934_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005,352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"37","key":"2934_CR4","doi-asserted-by":"publisher","first-page":"32843","DOI":"10.1074\/jbc.M111.260935","volume":"286","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Zhou Y, Shingu T, et al. Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis. J Biol Chem, 2011,286(37):32843\u201332853","journal-title":"J Biol Chem"},{"issue":"2","key":"2934_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1750-3639.2010.00460.x","volume":"21","author":"EE Bar","year":"2011","unstructured":"Bar EE. Glioblastoma, cancer stem cells and hypoxia. Brain Pathol, 2011,21(2):119\u2013129","journal-title":"Brain Pathol"},{"issue":"2","key":"2934_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF00182138","volume":"29","author":"BC Liang","year":"1996","unstructured":"Liang BC. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J Neurooncol, 1996,29(2):149\u2013155","journal-title":"J Neurooncol"},{"issue":"4","key":"2934_CR7","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.3171\/foc.2006.20.4.16","volume":"20","author":"RL Jensen","year":"2006","unstructured":"Jensen RL. Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg Focus, 2006,20(4):E24","journal-title":"Neurosurg Focus"},{"issue":"1","key":"2934_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/2045-9912.229600","volume":"8","author":"L Huang","year":"2018","unstructured":"Huang L, Boling W, Zhang JH. Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme. Med Gas Res, 2018,8(1):24\u201328","journal-title":"Med Gas Res"},{"issue":"6","key":"2934_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s11596-023-2799-1","volume":"43","author":"JQ Pan","year":"2023","unstructured":"Pan JQ, Tian ZM, Xue LB. Hyperbaric Oxygen Treatment for Long COVID: From Molecular Mechanism to Clinical Practice. Curr Med Sci, 2023,43(6):1061\u20131065","journal-title":"Curr Med Sci"},{"issue":"1","key":"2934_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1015832726054","volume":"58","author":"T Beppu","year":"2002","unstructured":"Beppu T, Kamada K, Yoshida Y, et al. Change of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol, 2002,58(1):47\u201352","journal-title":"J Neurooncol"},{"issue":"11","key":"2934_CR11","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1002\/cam4.851","volume":"5","author":"Z Lu","year":"2016","unstructured":"Lu Z, Ma J, Liu B, et al. Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice. Cancer Med, 2016,5(11):3147\u20133155","journal-title":"Cancer Med"},{"issue":"3","key":"2934_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11060-012-0923-3","volume":"109","author":"S Sun","year":"2012","unstructured":"Sun S, Lee D, Lee NP, et al. Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide. J Neurooncol, 2012,109(3):467\u2013475","journal-title":"J Neurooncol"},{"issue":"6","key":"2934_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1590\/S0102-86502012000600005","volume":"27","author":"Y Dag\u0131stan","year":"2012","unstructured":"Dag\u0131stan Y, Karaca I, Bozkurt ER, et al. Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model. Acta Cir Bras, 2012,27(6):383\u2013387","journal-title":"Acta Cir Bras"},{"issue":"1","key":"2934_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12951-019-0483-1","volume":"17","author":"X Zeng","year":"2019","unstructured":"Zeng X, Wang Q, Tan X, et al. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ\/PSi nanoparticles via decreasing the stemness in glioma. J Nanobiotechnology, 2019,17(1):47","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"2934_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11060-007-9407-2","volume":"85","author":"LE Stuhr","year":"2007","unstructured":"Stuhr LE, Raa A, Oyan AM, et al. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncol, 2007,85(2):191\u2013202","journal-title":"J Neurooncol"},{"issue":"10","key":"2934_CR16","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.3390\/cimb45100524","volume":"45","author":"CM Yuen","year":"2023","unstructured":"Yuen CM, Tsai HP, Tseng TT, et al. Hyperbaric Oxygen Therapy Adjuvant Chemotherapy and Radiotherapy through Inhibiting Stemness in Glioblastoma. Curr Issues Mol Biol, 2023,45(10):8309\u20138320","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"2934_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/ol.2015.3244","volume":"10","author":"YG Wang","year":"2015","unstructured":"Wang YG, Zhan YP, Pan SY, et al. Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis. Oncol Lett, 2015,10(1):189\u2013195","journal-title":"Oncol Lett"},{"issue":"7","key":"2934_CR18","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1177\/0300060518767796","volume":"46","author":"YG Wang","year":"2018","unstructured":"Wang YG, Long J, Shao DC, et al. Hyperbaric oxygen inhibits production of CD3+ T cells in the thymus and facilitates malignant glioma cell growth. J Int Med Res, 2018,46(7):2780\u20132791","journal-title":"J Int Med Res"},{"issue":"1","key":"2934_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41420-021-00486-0","volume":"7","author":"P Wang","year":"2021","unstructured":"Wang P, Gong S, Pan J, et al. Hyperbaric oxygen promotes not only glioblastoma proliferation but also chemosensitization by inhibiting HIF1\u03b1\/HIF2\u03b1-Sox2. Cell Death Discov, 2021,7(1):103","journal-title":"Cell Death Discov"},{"issue":"3","key":"2934_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.neuroscience.2009.01.062","volume":"159","author":"DP D\u2019Agostino","year":"2009","unstructured":"D\u2019Agostino DP, Olson JE, Dean JB. Acute hyperoxia increases lipid peroxidation and induces plasma membrane blebbing in human U87 glioblastoma cells. Neuroscience, 2009,159(3):1011\u20131022","journal-title":"Neuroscience"},{"issue":"6","key":"2934_CR21","first-page":"283","volume":"35","author":"QH Yu","year":"2020","unstructured":"Yu QH, Li DG, Zhang Q, et al. Effect of hyperbaric oxygen on survival of human glioma 172 cells. Chin J Rehab, 2020,35(6):283\u2013286","journal-title":"Chin J Rehab"},{"issue":"2","key":"2934_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11596-022-2515-6","volume":"42","author":"DW Wang","year":"2022","unstructured":"Wang DW, Su F, Yang LJ, et al. Bioinformatics Analysis and Identification of Potential Genes Associated with Pathogenesis and Prognosis of Gastric Cancer. Curr Med Sci, 2022,42(2):357\u2013372","journal-title":"Curr Med Sci"},{"issue":"1","key":"2934_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, et al. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genomics Proteomics Bioinformatics, 2021,19(1):1\u201312","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2934_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12935-020-01240-9","volume":"20","author":"Q Wu","year":"2020","unstructured":"Wu Q, Zhang B, Li B, et al. PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway. Cancer Cell Int, 2020,20:172","journal-title":"Cancer Cell Int"},{"key":"2934_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2021.02.019","volume":"506","author":"C Arienti","year":"2021","unstructured":"Arienti C, Pignatta S, Zanoni M, et al. High-pressure oxygen rewires glucose metabolism of patient-derived glioblastoma cells and fuels inflammasome response. Cancer Lett, 2021,506:152\u2013166","journal-title":"Cancer Lett"},{"issue":"1","key":"2934_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12935-022-02448-7","volume":"22","author":"Y Chen","year":"2022","unstructured":"Chen Y, Ji Y, Liu S, et al. PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A-mediated cell cycle progression. Cancer Cell Int, 2022,22(1):19","journal-title":"Cancer Cell Int"},{"key":"2934_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1022169107872","volume":"61","author":"T Beppu","year":"2003","unstructured":"Beppu T, Kamada K, Nakamura R, et al. A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-\u03b2 and nimustine hydrochloride to treat supratentorial malignant gliomas. J Neurooncol, 2003,61:161\u2013170","journal-title":"J Neurooncol"},{"issue":"1","key":"2934_CR28","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1038\/s41467-022-31340-1","volume":"13","author":"A Comba","year":"2022","unstructured":"Comba A, Faisal SM, Dunn PJ, et al. Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression. Nat Commun, 2022,13(1):3606","journal-title":"Nat Commun"},{"issue":"5","key":"2934_CR29","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1111\/jcmm.14896","volume":"24","author":"J Ma","year":"2020","unstructured":"Ma J, Weng L, Jia Y, et al. PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. J Cell Mol Med, 2020,24(5):2917\u20132930","journal-title":"J Cell Mol Med"},{"key":"2934_CR30","doi-asserted-by":"publisher","first-page":"101520","DOI":"10.1016\/j.tranon.2022.101520","volume":"25","author":"P Xie","year":"2022","unstructured":"Xie P, Zhang Y, Chen R, et al. PTBP3 promotes tumorigenesis of glioblastoma by stabilizing Twist1. Transl Oncol. 2022,25:101520","journal-title":"Transl Oncol"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2934-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T23:12:14Z","timestamp":1733872334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2934-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2934"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2934-7","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}